# Amundi MSCI Brazil ETF Acc- Capitalisation (RIOL)

**Source:** https://fundology.uk/fund/riol · ISIN LU1900066207 · Data: TradingView (LSE closes and returns, delayed), issuer documents and holdings (Amundi), ONS CPIH, FCA FIRDS

## At a glance

> Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.

As of 01/10/2026, RIOL (Amundi MSCI Brazil ETF Acc- Capitalisation, ISIN LU1900066207) closed at £22.48 on the London Stock Exchange. Its ongoing charge is 0.65% a year (about £65 on £10,000). Over the five years to 01/10/2026 its total return was +72.6%, or +34.9% after UK CPIH inflation.

## Summary

Amundi MSCI Brazil ETF Acc- Capitalisation is an exchange-traded fund (ETF) from Amundi, launched in 2019. It tracks the MSCI Brazil. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.65% a year — about £65 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

Latest close: **£22.48** (01/10/2026).

## Key facts

| Fact | Value |
|---|---|
| Ticker (LSE) | RIOL |
| ISIN | LU1900066207 |
| Category | Emerging markets |
| Type | ETF |
| Provider | Amundi |
| Tracks | MSCI Brazil |
| Income | Accumulating |
| Ongoing charge | 0.65% a year (£65 per £10,000) |
| Fund size | £255m |
| Launched | 2019 |
| Domicile | Luxembourg |

## Past returns (periods to 01/10/2026)

After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after ONS CPIH inflation.

| Window | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 1 year | +27.57% | +23.57% | income reinvested |
| 3 years | +34.84% | +21.68% | income reinvested |
| 5 years | +72.56% | +34.89% | income reinvested |

Returns: TradingView (delayed data). Inflation: ONS CPIH, latest month published.

## Calendar-year returns

Calendar-year returns of Amundi MSCI Brazil ETF Acc- Capitalisation in pounds (price, with income reinvested in the fund): 2022 +26.4%, 2023 +25.4%, 2024 −29.5%, 2025 +38.0%; 2026 to 01/10/2026 +19.7%. Returns of Amundi MSCI Brazil ETF Acc- Capitalisation in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: +27.5%; to 30/09/2025: +9.6%; to 30/09/2024: −5.9%; to 30/09/2023: +5.5%; to 30/09/2022: +21.9%.

| Year | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 2022 | +26.4% | +15.7% | Price |
| 2023 | +25.4% | +20.4% | Price |
| 2024 | -29.5% | -31.9% | Price |
| 2025 | +38.0% | +33.3% | Price |
| 2026 to 01/10/2026 | +19.7% | +16.4% | Price |

## Risk metrics

| Window | Volatility | Max drawdown |
|---|---|---|
| 1 year | 22.83% | -17.21% |
| 3 years | 20.22% | -29.45% |
| 5 years | 26.54% | -29.45% |

## Largest fall

Volatility of Amundi MSCI Brazil ETF Acc- Capitalisation in pounds, annualised from weekly returns to 01/10/2026: 22.8% over 1 year, 20.2% over 3 years, 26.5% over 5 years. Largest fall in the price of Amundi MSCI Brazil ETF Acc- Capitalisation since October 2021, in pounds: −29.5% from 29/12/2023 to 27/12/2024. The lowest 12-month return of Amundi MSCI Brazil ETF Acc- Capitalisation in pounds (price, with income reinvested in the fund) since January 2021 was −29.5% (12 months to 27/12/2024); the highest was +73.5% (12 months to 10/04/2026). On 01/10/2026 the price of Amundi MSCI Brazil ETF Acc- Capitalisation was 8.3% below its highest weekly close since October 2021 (10/04/2026), in pounds.

## Charges compared with similar funds

Ongoing charge of Amundi MSCI Brazil ETF Acc- Capitalisation 0.65% a year, as of 02/10/2026: 17 of the 141 other emerging-market share funds charge more, 12 the same and 112 less (share classes counted once).

## Funds tracking the same index

3 funds track MSCI Brazil, this one included and share classes counted once; their ongoing charges range from 0.25% to 0.74% a year (01/10/2026).

| Fund | Ongoing charge | 1 year | 3 years | 5 years |
|---|---|---|---|---|
| Amundi MSCI Brazil ETF Acc- Capitalisation (this fund) | 0.65% | +27.6% | +34.8% | +72.6% |
| iShares MSCI Brazil UCITS ETF USD (Dist) | 0.74% | +26.9% | +32.0% | +65.7% |
| Xtrackers MSCI BRAZIL UCITS ETF Capitalisation 1C | 0.25% | +27.9% | +35.5% | +72.5% |

Returns are the data vendor’s, in pounds, income reinvested unless marked "(price)".

## Charges & eligibility

- Ongoing charges figure (OCF): **0.65%** per year
- ISA eligible: yes
- SIPP eligible: yes

## What it holds

As of 29/09/2026, RIOL holds 30 positions, according to the holdings Amundi publishes. The largest is Apple at 8.07% of the fund; the ten largest make up 54.1%.

### Top holdings

Largest positions (as of 29/09/2026), as a percentage of the whole fund:

| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | Apple | [AAPL](https://fundology.uk/stock/AAPL) | 8.07% |
| 2 | Amazon | [AMZN](https://fundology.uk/stock/AMZN) | 7.85% |
| 3 | Advanced Micro Devices | [AMD](https://fundology.uk/stock/AMD) | 5.28% |
| 4 | Norfolk Southern | [NSC](https://fundology.uk/stock/NSC) | 4.93% |
| 5 | Micron Technology | [MU](https://fundology.uk/stock/MU) | 4.80% |
| 6 | Eli Lilly and | [LLY](https://fundology.uk/stock/LLY) | 4.66% |
| 7 | AbbVie | [ABBV](https://fundology.uk/stock/ABBV) | 4.64% |
| 8 | Intel | [INTC](https://fundology.uk/stock/INTC) | 4.64% |
| 9 | NVIDIA | [NVDA](https://fundology.uk/stock/NVDA) | 4.64% |
| 10 | Procter & Gamble | [PG](https://fundology.uk/stock/PG) | 4.64% |

Source: Amundi, holdings as published, as of 29/09/2026.

## Where it invests

Shares of the whole fund. Bonds, cash and positions the source does not classify are shown as they come, not guessed.

### By sector

As published by Amundi, as of 29/09/2026.

| Sector | Weight |
|---|---|
| Information Technology | 38.2% |
| Consumer Staples | 12.9% |
| Consumer Discretionary | 11.6% |
| Health Care | 11.4% |
| Industrials | 9.6% |
| Communication Services | 7.9% |
| Energy | 4.2% |
| Materials | 3.7% |
| Other sectors | 0.5% |

### By country

As published by Amundi, as of 29/09/2026.

| Country | Weight |
|---|---|
| United States | 92.3% |
| France | 7.7% |

The 29 holdings on record (of 30 Amundi reports): https://fundology.uk/fund/riol/holdings

## Questions people ask

**What is the ongoing charge of RIOL?**

The ongoing charge of RIOL is 0.65% a year — about £65 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of Amundi MSCI Brazil ETF Acc- Capitalisation 0.65% a year, as of 02/10/2026: 17 of the 141 other emerging-market share funds charge more, 12 the same and 112 less (share classes counted once).

**What does RIOL track?**

RIOL tracks the MSCI Brazil.

**Is RIOL accumulating or distributing?**

RIOL is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

**What is the ISIN of RIOL?**

The ISIN of RIOL is LU1900066207. An ISIN identifies one exact share class of a fund; RIOL is its ticker on the London Stock Exchange.

**What does RIOL hold?**

As of 29/09/2026, RIOL holds 30 positions, according to the holdings Amundi publishes. The largest is Apple at 8.07% of the fund; the ten largest make up 54.1%. Its ten largest holdings are Apple (8.07%), Amazon (7.85%), Advanced Micro Devices (5.28%), Norfolk Southern (4.93%), Micron Technology (4.80%), Eli Lilly and (4.66%), AbbVie (4.64%), Intel (4.64%), NVIDIA (4.64%) and Procter & Gamble (4.64%).

**What were RIOL’s returns in each of the last five years?**

Calendar-year returns of RIOL in pounds (price, with income reinvested in the fund): 2022 +26.4%, 2023 +25.4%, 2024 −29.5%, 2025 +38.0%; 2026 to 01/10/2026 +19.7%. Past performance is not a guide to future returns.

**How has RIOL done after inflation?**

Over the five years to 01/10/2026 RIOL’s total return was +72.6%, or +34.9% after UK CPIH inflation. Past performance is not a guide to future returns.

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.